ProShares Ultra NASDAQ Biotechnology
22 hedge funds and large institutions have $8.2M invested in ProShares Ultra NASDAQ Biotechnology in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
5
Closed
4
Calls
$2.59M
Puts
$1.21M
Net Calls
+$1.38M
Net Calls Change
+$2.05M